Portfolio
Start-up partners rise to the challenge
Better cancer care from home. Virtual education for clinicians. AI to manage chronic diseases. Software to streamline hospital staffing. Our start-up partners are re-imagining how to enable better, lower-cost care that customers need.
Current Philips Health Technology Ventures Fund portfolio
Our business-agnostic Philips Health Technology Ventures Fund directly invests in digital software- and technology-enabled services.
Mytonomy is building patient education for Philips customers that are moving toward actionable, population health-driven insights.
Carevive software embedded in hospitals’ EMR workflows generate personalized oncology care plans and remotely monitors patients’ symptoms.
Orbita built a voice-driven AI platform so people can access, receive and manage healthcare anywhere, and can access information on devices such as Alexa.
Bright.md uses an AI-powered care automation platform to create a virtual front door through which patients can navigate, be triaged, receive care for low-acuity conditions or be routed to in-person or video visits.
Xealth created a digital health prescribing platform that now enables providers to monitor Philips home-based respiratory solutions.
DearHealth offers an AI-powered clinical care pathway platform for chronic disease management.
Examples of Philips business-sponsored start-ups
Philips Ventures orchestrates collaborations and investments between Philips businesses and select start-ups.
BioIntelliSense is a continuous health monitoring company that has created remote patient monitoring solutions used outside of the hospital.
CareTaker Medical developed a noninvasive finger cuff for continual blood pressure and vital sign monitoring in high-acuity settings.
BioBright automates data flow from lab instruments to a secure cloud to standardize and analyze data.
Common Sensing is a dose monitoring solution enabling patients and providers to better use injectable medicine, including insulin.
Lifetrack Medical Systems improves access to medical imaging services through a radiology software designed to quickly produce high-quality diagnostic reports.
Pedra Technology develops perfusion technologies for the diagnosis and management of peripheral artery disease.
Noninvasix invented technology that can replace invasive, intermittent diagnostic testing of key measurements with novel noninvasive patient monitoring methods.
Philips Ventures is synonymous with acceleration and sharpening our main value proposition.”
Fabian Kording
CEO, Northh-medical
Its mission: the Hamburg, Germany-based company aims to establish fetal cardiac MRI in clinical practices for better fetal care
Interested in becoming a start-up partner
with Philips?
You are about to visit a Philips global content page
You are about to visit the Philips USA website.
You are about to visit a Philips global content page
You are about to visit the Philips USA website.